First nine months of 2019 financial results

 

On 1 November 2019 Novo Nordisk A/S announced the results for the first nine months of 2019.

Financial results material:
• Financial results
• Downloadable financial data


Investor presentation:

• Investor presentation


Q3 2019 conference call on Friday, 1 November 2019 (13.00 CET) 
• Webcast link
• Conference call presentation

To access the conference call, please call the following numbers:

Denmark:

UK and international:

USA:

+45 3272 0417 (conference code 5954419#)

+44 (0) 207 192 8338 (conference code 5954419#)

+1 646 741 3167 (conference code 5954419#)

 

Q3 2019 investor presentation webcast on Monday, 4 November 2019 (14.15 CET)
• Webcast link
• Webcast presentation

 

If you have any questions, you are welcome to contact Novo Nordisk Investor Relations: 

+45 3075 9085              Peter Hugreffe Ankersen
+45 3079 0301
              Valdemar Borum Svarrer
+45 3075 2253              Ann Søndermølle Rendbæk
+45 3079 4211              Mark Joseph Root       
+1 609 235 2989           Kristoffer Due Berg (US)